Sitagliptin Metformin/PPARg Agonist Combination Therapy Add-on (0431-052)

Condition: Type 2 Diabetes MellitusInterventions: Drug: sitagliptin; Drug: Comparator: Placebo; Drug: rosiglitazone; Drug: metformin; Drug: glipizideSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014

http://clinicaltrials.gov/ct2/show/NCT00350779?lup_s=10%2F11%2F2014&lup_d=30

Source: ClinicalTrials.gov - July 7, 2006 Category: Research Source Type: clinical trials